VRS
CERE

Virginia Retirement Systems’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Virginia Retirement Systems’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$343K Hold
9,800
– – ﹤0.01% 947
2021
Q4 		$318 Hold
9,800
– – ﹤0.01% 972
2021
Q3 		$289K Buy
+9,800
New +$275K ﹤0.01% 891

Other funds holding CERE

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Virginia Retirement Systems's CERE Position: Q1 2022 in Review

Virginia Retirement Systems held its Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) position steady in Q1 2022 at 9,800 shares worth $343K. The position accounts for ﹤0.01% of the portfolio, ranked #947.

Virginia Retirement Systems first reported a position in CERE in Q3 2021 and has held it in 3 quarters since. 107 funds tracked by Wall St. Rank hold CERE as of Q1 2022.

  • Virginia Retirement Systems held 9,800 shares of Cerevel Therapeutics Holdings, Inc. Common Stock worth $343K as of Q1 2022.
  • Virginia Retirement Systems left its Cerevel Therapeutics Holdings, Inc. Common Stock share count unchanged in Q1 2022.
  • Cerevel Therapeutics Holdings, Inc. Common Stock made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q1 2022, its #947 holding.
  • Virginia Retirement Systems first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2021 and has held it in 3 quarters since.
  • 107 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q1 2022.

Based on Virginia Retirement Systems's 13F filing for Q1 2022, filed 21 Apr 2022.